gemtuzumab

DRUG2 trials

Sponsors

PETHEMA Foundation, M.D. Anderson Cancer Center

Conditions

Acute Myeloblastic LeukemiaAcute Myeloid Leukemia

Phase 1

A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

RecruitingNCT06448013

M.D. Anderson Cancer CenterAcute Myeloid Leukemia

Start: 2025-03-07End: 2030-12-31Target: 22Updated: 2025-12-15

Phase 4

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

CompletedNCT01041040

PETHEMA FoundationAcute Myeloblastic Leukemia

Start: 2007-10-31End: 2013-01-31Updated: 2013-07-31